FDA Updates Congress On CBD Product Labelling Accuracy
The Food and Drug Administration (FDA) submitted a report to Congress on the state of the CBD marketplace on Wednesday, and the document outlines studies the agency has performed on the contents and quality of cannabis-derived products that it has tested over the past six years. The report, which is responsive to a mandate attached … Continue reading FDA Updates Congress On CBD Product Labelling Accuracy
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed